Connecticut was one of 18 states to have a strong presence at the BIO International Convention, held this week in Boston. It was a record-setting year, as 18,289 U.S. and international attendees – the most in the last 10 years – participated in what was described as “the epicenter of the biotechnology industry” for four days of programming, 46, 916 partnering meetings (setting a new Guinness World Record for “The Largest Business Partnering Event”) and entertainment.
More than a dozen Connecticut companies had a presence in the state’s pavilion at the event: Jackson Laboratory, Sema4, Genotech Matrix, AlvaHealth, RallyBio, Cantor Colburn, Pfizer, e-Path Learning, Thetis Pharmaceuticals, XViVO, Clarity Quest, Lucerna, Wyant Simboli, Boehringer Ingelheim, Aeromics, LambdaVision, Pattern Genomics.
Also participating were Southern Connecticut State University, Yale University and the University of Connecticut, as well as the City of New Haven, and the town of Branford, along with BIO CT, Connecticut Innovations and the Connecticut Department of Economic and Community Development. Additional companies from the state were on-hand, although not as part of the state’s coordinated effort.
All told, there were more than 1,000 companies from dozens of nations represented at the 25th anniversary conference. The organizations represented at the BIO International Convention include the world’s leading biotech companies, top 25 pharma companies, top 20 CROs and CMOs, and more than 300 academic institutions including the major research labs and government agencies. Organizers indicate that one out of three attendees based outside of the U.S. and nearly 40 percent are C-level executives at their respective companies.
“If you are or want to be any type of a life science hub, you need to be at this convention,” Dawn Hocevar, president and CEO of BioCT, recently told New Haven BIZ. “Connecticut participated in the last two conventions, however, this is the largest footprint we’ve ever had.” BioCT is the bioscience industry voice for the state of Connecticut. BioCT is dedicated to growing the vibrant bioscience ecosystem in Connecticut by supporting innovation, collaboration, networking, education, talent engagement and advocacy.
This year’s educational programming was more robust and diverse than ever before, according to organizers, with more than 180 educational sessions, including brand new tracks on genome editing, opioids and corporate best practices.
Among the presenters, panelists, and featured speakers was Scott Gottlieb, Commissioner of Food and Drugs at the U.S. Food and drug Association, a graduate of Wesleyan University in Middletown.